Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jan Korniluk"'
Autor:
Jolanta Żok, Michał Bieńkowski, Barbara Radecka, Jan Korniluk, Krzysztof Adamowicz, Renata Duchnowska
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Oxaliplatin-based therapy with FOLFOX-4 or CAPOX administered over 6 months remains the standard adjuvant treatment for stage III colon cancer (CC) patients. However, many patients experience dose reduction or early termination of
Externí odkaz:
https://doaj.org/article/b1e671b827f04f34930b620857b524a5
Autor:
Piotr Piasecki, Jerzy Narloch, Krzysztof Brzozowski, Piotr Zięcina, Andrzej Mazurek, Anna Budzyńska, Jan Korniluk, Mirosław Dziuk
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200488 (2018)
CONCLUSION:The mT/N1 ratio, PAD, and AAD can be used as predictors of tumor response to SIRT treatment, and SPECT/CT imaging can be used for dosimetric assessment of radioembolization.
Externí odkaz:
https://doaj.org/article/52e8f316b45d4d0db16697a237c6b4b7
Autor:
Jan Korniluk, Krzysztof Adamowicz, Barbara Radecka, Renata Duchnowska, Michał Bieńkowski, Jolanta Żok
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Background Oxaliplatin-based therapy with FOLFOX-4 or CAPOX administered over 6 months remains the standard adjuvant treatment for stage III colon cancer (CC) patients. However, many patients experience dose reduction or early termination of chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3243857b230c58c2afdc34323e7f62d8
https://doi.org/10.21203/rs.3.rs-35659/v2
https://doi.org/10.21203/rs.3.rs-35659/v2
Autor:
Barbara Moszczuk, Anna M. Czarnecka, Krzysztof Bogusz, Paweł Sobczuk, Jan Korniluk, Cezary Szczylik, Anna Owczarek, Dominika Labochka, Anna Brodziak, Marta Spychalska
Publikováno v:
Future Oncology. 13:31-49
Aim: The study aim was to evaluate progression-free survival (PFS) and overall survival (OS) in patients with metastatic clear cell renal cell carcinoma on sunitinib (SU) and SU–everolimus treatment. Patients & methods: After 7 years of enrollment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8bb50da9dc9c3221e73867a8a23922a
https://doi.org/10.2217/fon-2016-0355
https://doi.org/10.2217/fon-2016-0355
Autor:
Dominika Labochka, Ewa Bartnik, Cezary Szczylik, Cezary Dendek, Anna Brodziak, Paweł Sobczuk, Anna M. Czarnecka, Jan Korniluk
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
The aim of this study was to investigate the prognostic impact of baseline tumor burden and loci on the efficacy of first line renal cancer treatment with sunitinib. Baseline and on-treatment CT scans were evaluated. Both the Kaplan-Meier and Weibull
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68db73abd980bdc8c0b292b977ff93ca
https://pubmed.ncbi.nlm.nih.gov/31123336
https://pubmed.ncbi.nlm.nih.gov/31123336
Autor:
Andrzej Mazurek, Jan Korniluk, Piotr Piasecki, Mirosław Dziuk, Anna Budzyńska, Piotr Zięcina, Jerzy Narloch, Krzysztof Brzozowski
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200488 (2018)
PLoS ONE
PLoS ONE
The aim of this study was to evaluate a modified method of calculating the 99mTc/90Y tumor-to-normal-liver uptake ratio (mT/N) based on SPECT/CT imaging, for use in predicting the overall response of colorectal liver tumors after radioembolization. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3bd615323646d3215e3d1298b8be89e
http://europepmc.org/articles/PMC6039046?pdf=render
http://europepmc.org/articles/PMC6039046?pdf=render
Autor:
Jan Korniluk, Mirosław Dziuk, Grzegorz Kamiński, Piotr Piasecki, Anna Budzyńska, Krzysztof Brzozowski, Zbigniew Podgajny, Piotr Zięcina
Publikováno v:
Nuclear Medicine Review. 18:92-96
BACKGROUND: Selective internal radiation therapy (SIRT) with 90Y-microspheres infusion into the hepatic artery is a novel method for palliative treatment of primary and metastatic liver cancer. The post-procedural 90Y dose estimation in the liver is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5db95b81ad44d0d5f5b106b66b80dd9a
https://doi.org/10.5603/nmr.2015.0022
https://doi.org/10.5603/nmr.2015.0022
Multidisciplinary approach associated with improved overall survival in metastatic colorectal cancer
Autor:
Barbara Radecka, Michał Bieńkowski, Renata Duchnowska, Jan Korniluk, J Zok, Krzysztof Adamowicz
Publikováno v:
Annals of Oncology. 30:iv10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1667d7b470aa205825c4565cd39cc603
https://doi.org/10.1093/annonc/mdz155.035
https://doi.org/10.1093/annonc/mdz155.035
Autor:
Rafał Stec, Radoslaw Charkiewicz, Jan Korniluk, Wojciech Kozłowski, Marta Smoter, Lubomir Bodnar, Marzena Ciechowicz, Cezary Szczylik, Marta Rokita, Jacek Niklinski, Lech Chyczewski
Publikováno v:
Cancer Biology & Therapy
Background: CRC caused more than 600,000 estimated deaths in 2008. Dysregulated signaling through the RAS/RAF/mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway due to mutations in K-Ras and B-Raf are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb7e9ca7aff57006767224e2b383635
https://doi.org/10.4161/cbt.21813
https://doi.org/10.4161/cbt.21813
Autor:
Jan Korniluk, Barbara Radecka, Renata Duchnowska, Marlena Orlikowska, Krzysztof Adamowicz, J Zok
Publikováno v:
Annals of Oncology. 28:iii100-iii101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a04d1e59d179826b6fbd8df4b6177279
https://doi.org/10.1093/annonc/mdx261.284
https://doi.org/10.1093/annonc/mdx261.284